What class is Gvoke (gvoke) hypopen in?
Gvoke is a brand of glucagon used for severe low blood sugar (severe hypoglycemia) when a person with diabetes can’t safely take sugar by mouth. It belongs to the glucagon drug class (an anti-hypoglycemic hormone).
What does “hypopen” mean for Gvoke?
“Hypopen” refers to the auto-injector device format for a glucagon medicine. So, Gvoke HypoPen is essentially a glucagon product delivered via a hypoglycemia rescue injector.
How does Gvoke work (drug class mechanism)?
As a glucagon product, Gvoke works by raising blood glucose. Clinically, glucagon helps correct severe hypoglycemia by stimulating glucose release from the liver.
What conditions is this class used for?
This glucagon class is used for rescuing severe hypoglycemia, including situations where the person is unconscious, having seizures, or otherwise unable to swallow.
Are there other glucagon products like Gvoke?
Yes. Gvoke is one glucagon option, and there are other glucagon rescue formulations and devices (for example, nasal and injectable products) that also fall under the glucagon drug class, even if the device and brand differ.
Where to check patents or exclusivity for Gvoke’s glucagon formulations
For patent and exclusivity-related research tied to specific glucagon products and formulations, DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com